Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
BRITISH JOURNAL OF DERMATOLOGY
; 187:11-11, 2022.
Article
in English
| Web of Science | ID: covidwho-1935217
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Language:
English
Journal:
BRITISH JOURNAL OF DERMATOLOGY
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS